CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.

Pharmaceutical

CStone Pharmaceuticals

Jason Yang

Jason Li

Lian Liu

Qingmei Shi

Na Wen

Chao Arthur Wu

Juan Zhang

Anny-Yue Yin

Michael Choi

Josh Zhou

The Clinical and Medical Science Team at CStone Pharmaceuticals is responsible for designing and overseeing clinical trials, ensuring adherence to regulatory standards, and generating clinical data to support the efficacy and safety of the company's oncology-focused drug candidates. This multidisciplinary team collaborates closely to advance CStone’s pipeline through various stages of clinical development, from early-phase trials to pivotal registration stages, with a strong emphasis on immuno-oncology and precision medicines.

Clinical and Medical Science Team

Leadership Team

Marketing and Communications

Clinical and Medical Science Team

About

Team members

Other teams at CStone Pharmaceuticals

Leadership Team

Marketing and Communications